Dow Up0.76% Nasdaq Up0.69%

Galectin Therapeutics, Inc. (GALT)

-NasdaqCM
5.09 Up 0.35(7.38%) Oct 24, 4:00PM EDT
Balance SheetGet Balance Sheet for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Assets
Current Assets
Cash And Cash Equivalents10,489  9,364  6,397  
Short Term Investments -   -   -  
Net Receivables -   -   -  
Inventory -   -   -  
Other Current Assets198  153  104  
Total Current Assets 10,687   9,517   6,501  
Long Term Investments -   -   -  
Property Plant and Equipment3  8  6  
Goodwill -   -   -  
Intangible Assets23  30  36  
Accumulated Amortization -   -   -  
Other Assets -  6  69  
Deferred Long Term Asset Charges -   -   -  
Total Assets 10,713   9,561   6,612  
Liabilities
Current Liabilities
Accounts Payable2,486  1,638  2,015  
Short/Current Long Term Debt -   -   -  
Other Current Liabilities -   -  200  
Total Current Liabilities 2,486   1,638   2,215  
Long Term Debt -   -   -  
Other Liabilities -  6   -  
Deferred Long Term Liability Charges -   -   -  
Minority Interest -   -   -  
Negative Goodwill -   -   -  
Total Liabilities 2,486   1,644   2,215  
Stockholders' Equity
Misc Stocks Options Warrants -   -   -  
Redeemable Preferred Stock6,746  6,752  6,522  
Preferred Stock587  632  632  
Common Stock18  16  13  
Retained Earnings(101,965)(80,018)(69,137)
Treasury Stock -   -   -  
Capital Surplus102,841  80,535  66,367  
Other Stockholder Equity -   -   -  
Total Stockholder Equity 1,481   1,165   (2,125)
Net Tangible Assets 1,458   1,135   (2,161)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.